-
2023-508868-30-00
5
2022-09-26
Treatment of stereotypical prolonged seizure
-
2023-510384-36-00
5
2022-09-13
Newly Diagnosed Multiple Myeloma
-
2023-507557-16-00
5
2022-08-31
chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive
-
2023-507699-38-00
5
2022-08-30
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
-
2024-510950-29-00
5
2022-07-21
Stereotypical prolonged seizure
-
2023-510278-14-00
5
2022-06-16
Niemann-Pick disease type C
-
2023-503267-42-00
5
2022-06-10
Patients with a histological diagnosis of mismatch- repair deficient h
-
2024-513412-10-00
9
2022-05-11
Anaplastic Large Cell Lymphoma (ALCL)
-
2024-512089-32-00
3
2022-03-28
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
-
2023-508963-58-00
4
2022-01-31
Symptomatic hypertrophic cardiomyopathy (HCM)
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-510578-25-00
5
2021-11-05
Histologically proven high-risk medulloblastoma, with any of the curre
-
2024-516728-32-00
10
2021-10-29
Indolent Systemic Mastocytosis and SSM
-
2024-516846-20-00
5
2021-09-26
Patent Ductus Arteriosus
-
2024-512982-15-00
5
2021-06-28
BRCA Mutated Ovarian Cancer Patients, Epithelian ovarian cancer, Metas
-
2024-510815-30-00
1
2021-06-02
Relapsed/refractory CD19+ Acute Lymphoblastic Leukaemia and Non-Hodgki
-
2024-512671-12-00
10
2021-03-05
Unresectable head and neck squamous cell carcinoma, metastatic head an
-
2023-504417-67-00
6
2020-12-22
Psoriatic Arthritis, Ankylosing Spondylitis, Non-radiographic Axial Sp
-
2024-516649-38-00
5
2020-12-01
Recurrent ovarian, fallopian tube or primary peritoneal cancer
-
2024-510579-40-00
9
2020-10-07
Rhabdoyosarcoma
-
2024-519687-40-00
10
2020-09-11
diabetic foot syndrome
-
2024-517391-38-00
6
2020-09-09
End-stage kidney disease in Type 1 diabetes
-
2024-512186-14-00
6
2020-08-24
Fluid overload/fluid accumulation
-
2022-501456-28-00
5
2020-07-20
atypical teratoid/rhabdoid tumours (ATRT)